Tokunaga Takuya, Shukunami Chisa, Okamoto Nobukazu, Taniwaki Takuya, Oka Kiyoshi, Sakamoto Hidetoshi, Ide Junji, Mizuta Hiroshi, Hiraki Yuji
Department of Orthopaedic Surgery, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan.
Department of Molecular Biology and Biochemistry, Division of Basic Life Sciences, Institute of Biomedical & Health Sciences, Hiroshima University, Hiroshima, Japan.
Am J Sports Med. 2015 Oct;43(10):2411-22. doi: 10.1177/0363546515597488. Epub 2015 Aug 26.
Fibroblast growth factor (FGF)-2 has the potential to enhance tendon-to-bone healing after rotator cuff (RC) injury.
FGF-2 stimulates tenogenic differentiation of progenitors to improve the biomechanical strength and histological appearance of repaired RCs in rats.
Controlled laboratory study.
Adult male Sprague-Dawley rats (N = 156) underwent unilateral surgery to repair the supraspinatus tendon to insertion sites. The FGF-2-treated group (gelatin hydrogel containing 5 μg of FGF-2) and a control group (gelatin hydrogel only) were compared to investigate the effects of FGF-2 at 2, 4, 6, 8, and 12 weeks postoperatively. Biomechanical testing was performed at 6 and 12 weeks. Semiquantitative histological analysis and immunohistochemical analysis for the proliferating cell nuclear antigen (PCNA) were performed, and the expression of tendon-related markers, including Scleraxis (Scx) and Tenomodulin (Tnmd), was monitored by real-time reverse transcription polymerase chain reaction (RT-PCR) and in situ hybridization. SRY-box containing gene 9 (Sox9) expression was monitored by RT-PCR and immunohistochemical analysis. At 2 and 4 weeks, immunohistochemical analysis for mesenchymal stem cell (MSC) markers was also performed.
The FGF-2-treated group demonstrated a significant improvement in mechanical strength at 6 and 12 weeks and significantly higher histological scores than the control group at ≥4 weeks. The average incidence of PCNA-positive cells was significantly higher at 2 and 4 weeks, and more cells expressing MSC markers were detected at the insertion site in the FGF-2-treated group. The expression level of Scx increased significantly in the FGF-2-treated group from 4 to 8 weeks, while the Tnmd level increased significantly from 4 to 12 weeks postoperatively. The localization of Tnmd overlapped with the locations of reparative tissues accompanying collagen fibers with an aligned orientation. Sox9 expression was significantly upregulated at 4 weeks in the FGF-2-treated group.
FGF-2 promotes growth of the tenogenic progenitor cells, which participate in tendon-to-bone healing, resulting in biomechanical and histological improvement of the repaired RC.
These findings provide clues regarding the clinical development of regenerative repair strategies for RC injury.
成纤维细胞生长因子(FGF)-2 有增强肩袖(RC)损伤后肌腱-骨愈合的潜力。
FGF-2 刺激祖细胞向肌腱细胞分化,以改善大鼠修复后 RC 的生物力学强度和组织学外观。
对照实验室研究。
成年雄性 Sprague-Dawley 大鼠(N = 156)接受单侧手术,将冈上肌腱修复至附着部位。比较 FGF-2 治疗组(含 5 μg FGF-2 的明胶水凝胶)和对照组(仅明胶水凝胶),以研究术后 2、4、6、8 和 12 周时 FGF-2 的作用。在 6 周和 12 周时进行生物力学测试。进行半定量组织学分析和增殖细胞核抗原(PCNA)的免疫组化分析,并通过实时逆转录聚合酶链反应(RT-PCR)和原位杂交监测包括硬骨素(Scx)和肌腱调节蛋白(Tnmd)在内的肌腱相关标志物的表达。通过 RT-PCR 和免疫组化分析监测含 SRY 盒基因 9(Sox9)的表达。在 2 周和 4 周时,还进行了间充质干细胞(MSC)标志物的免疫组化分析。
FGF-2 治疗组在 6 周和 12 周时机械强度有显著改善,且在≥4 周时组织学评分显著高于对照组。PCNA 阳性细胞的平均发生率在 2 周和 4 周时显著更高,且在 FGF-2 治疗组的附着部位检测到更多表达 MSC 标志物的细胞。FGF-2 治疗组中 Scx 的表达水平在术后 4 至 8 周显著增加,而 Tnmd 水平在术后 4 至 12 周显著增加。Tnmd 的定位与胶原纤维排列方向一致的修复组织位置重叠。FGF-2 治疗组在 4 周时 Sox9 表达显著上调。
FGF-2 促进参与肌腱-骨愈合的肌腱祖细胞生长,从而改善修复后 RC 的生物力学和组织学状况。
这些发现为 RC 损伤再生修复策略的临床开发提供了线索。